April 25, 2020

Lately my email has been full of information on the increased risk of death from Covid-19 if you have diabetes. There is evidently enough clamor that insulin companies are offering special discounts and free insulin to patients. I think that it is great, but why did it take an epidemic to make insulin prices go down? More importantly, will they go back up when the pandemic is over?

This points out the dilemma that many medical professionals face when they manage complex patients. This week we have part 2 of our series, on Cost Vs Outcomes, that delves into why medication prices are so high.

*****************************

We can make a difference!

*****************************

Dave Joffe

Editor-in-chief